We want to understand the total environmental footprint of the processes used to make our products.
This means measuring the impacts of our suppliers of active pharmaceutical ingredients and packaged products, as well as those from our own operations. Some of our improvements in hazardous waste and air emissions were due to outsourcing of some production processes. Until we can collect data from our suppliers we will not know the full impact of production of our products. In the future we hope to report on the combined environmental impacts of manufacturing at GSK facilities and at our contract manufacturers.
GSK selects suppliers with an appropriate level of EHS management systems control. However, over the past few years it has proved difficult to obtain environment, health and safety performance data from these suppliers just for the products that they manufacture for GSK. In 2007 we surveyed 52 suppliers and received a response from 21 (40 per cent). They indicated that they preferred providing data after the first quarter of the year to give them time to review it. With this input from our suppliers we changed our process. For energy data we will join the Carbon Disclosure Project (CDP) supplier initiative and request energy and climate change data from our large suppliers through the CDP. We will collect 2008 water, waste and injury and illness data from suppliers during the second quarter of 2009 using our electronic system. We published the 2007 data in our 2007 corporate responsibility report and will publish 2008 data in the 2009 report.
Read more about GSK’s supply chain.

